Publication:
Ethics and reproductive health: The issue of HPV vaccination

dc.contributor.authorMatejić, Bojana (9840705300)
dc.contributor.authorKesić, Vesna (6701664626)
dc.date.accessioned2025-06-12T21:25:10Z
dc.date.available2025-06-12T21:25:10Z
dc.date.issued2013
dc.description.abstractThe ethics of reproductive health covers a wide field of different issues, from the ethical dimensions of assisted reproduction, life of newborns with disabilities to the never-ending debate on the ethical aspects of abortion. Furthermore, increasing attention is paid to the ethical dimensions of using stem cells taken from human embryos, the creation of cloned embryos of patients for possible self-healing, and the increasingly present issue of reproductive cloning. Development of vaccines against human papillomavirus (HPV) has introduced new ethical aspects related to reproductive health and the need for a consensus of clinical and public-healthcare population. Today immunization with HPV vaccine is a measure for the primary prevention of cervical cancer and it provides effective protection against certain types of viruses included in the vaccine. The most often mentioned issues of discussions on ethical concerns about HPV vaccination are the recommended age of girls who should be informed and vaccinated (12-14 years), attitudes and fears of parents concerning discussion with their preadolescent daughters on issues important for their future sexual behavior, dilemma on the vaccination of boys and the role of the chosen pediatrician in providing information on the vaccination. In Serbia, two HPV vaccines have been registered but the vaccination is not compulsory. Up-till-now there has been no researches on the attitudes of physicians and parents about HPV vaccination. Nevertheless, it is very important to initiate education of general and medical public about the fact that the availability of vaccine, even if we disregard all aforementioned dilemmas, does not lead to the neglect of other preventive strategies against cervical cancer, primarily screening. The National Program for Cervical Cancer Prevention involves organized screening, i.e. regular cytological examinations of the cervical smear of all women aged 25-69 years, every three years, regardless of the vaccination status.
dc.identifier.urihttps://doi.org/10.2298/SARH1302127M
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84940311380&doi=10.2298%2fSARH1302127M&partnerID=40&md5=90e17a16ec8b370e6fb2afd536c4ca95
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/9302
dc.subjectEthics
dc.subjectHuman papillomavirus (HPV)
dc.subjectReproductive health
dc.subjectVaccination
dc.titleEthics and reproductive health: The issue of HPV vaccination
dspace.entity.typePublication

Files